Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2023-12-10 2023-03-01
Drug Identification Number 02231962 02231962
Brand name CYTOGAM CYTOGAM
Common or Proper name CYTOMEGALOVIRUS IMMUNE GLOBULIN (HUMAN) CYTOMEGALOVIRUS IMMUNE GLOBULIN (HUMAN)
Company Name KI BIOPHARMA LLC KI BIOPHARMA LLC
Ingredients CYTOMEGALOVIRUS IMMUNOLOBULIN CYTOMEGALOVIRUS IMMUNOLOBULIN
Strength(s) 2500MG 2500MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 50 ML 50 ML
ATC code J06BB J06BB
ATC description IMMUNOGLOBULINS IMMUNOGLOBULINS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2023-06-15 2023-06-15
Actual start date
Estimated end date 2024-01-15 2024-01-15
Actual end date 2023-12-07
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Technology Transfer from CSL to Kamada Technology Transfer from CSL to Kamada
Health Canada comments